GENE ONLINE|News &
R&D
Amgen Makes Second Acquisition Move Within a Month, Bolsters Inflammatory Disease Portfolio
2021-04-02
Takeda to Pursue Hard-to-Drug Neurodegenerative Disease Targets with BridGene Biosciences
2021-04-01
uniQure’s Inquiry Shows Hemophilia B Gene Therapy not Likely to Have Induced Liver Cancer
2021-03-30
BMS, bluebird’s Multiple Myeloma Drug Becomes First BCMA Targeting CAR-T Therapy to Snag FDA Okay
2021-03-28
Genentech Seeks FDA’s Blessings after Adjuvant Tecentriq Shows Promising Result in Lung Cancer Patients
2021-03-23
Illumina Looks to Consolidate NGS Market in APAC Region, Collaborates with Geneseeq to Develop IVD Kits in China
2021-03-21
